|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2023―Mrz―23 |
Multiscale network analysis identifies potential receptors for
SARS-CoV
-2 and reveals their tissue-specific and age-dependent expression |
Christian V. Forst, Lu Zeng, Qian Wang, Xianxiao Zhou, Sezen Vatansever, Peng Xu, et al. (+3) Won-Min Song, Zhidong Tu, Bin Zhang |
2 |
[GO] |
2022―Sep―02 |
SARS-CoV
-2 spike protein aggregation is triggered by bacterial lipopolysaccharide |
Jitka Petrlova, Firdaus Samsudin, Peter J. Bond, Artur Schmidtchen |
3 |
[GO] |
2022―Aug―28 |
Middle East respiratory syndrome coronavirus
ORF4b
protein inhibits
TLR7
- and
TLR9
-dependent alpha interferon induction |
Yoshinori Kitagawa, Takumi Tsukamoto, Masae Itoh, Bin Gotoh |
4 |
[GO] |
2022―Jul―27 |
Expanding the Antiviral Potential of the Mosquito Lipid-transfer Protein
AEG12
Against
SARS-CoV
-2 Using Hydrophobic Antiviral Ligands |
Alexander C.Y. Foo, Bernard A.P. Lafont, Geoffrey A. Mueller |
5 |
[GO] |
2022―Apr―18 |
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation |
Pravin Kumar, Erin Schexnaydre, Karim Rafie, Tatsuaki Kurata, Ilya Terenin, Vasili Hauryliuk, Lars-Anders Carlson |
6 |
[GO] |
2022―Mrz―18 |
SARS-CoV-2 3CL
pro
displays faster self-maturation
in vitro
than SARS-CoV 3CL
pro
due to faster C-terminal cleavage |
Chih-Jung Kuo, Po-Huang Liang |
7 |
[GO] |
2021―Nov―16 |
Two years into COVID-19 - Lessons in SARS-CoV-2 and a perspective from papers in
FEBS Letters |
Urs F. Greber |
8 |
[GO] |
2021―Nov―15 |
SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets |
Syam Prakash Somasekharan, Martin Gleave |
9 |
[GO] |
2021―Nov―10 |
Neurological Pathophysiology of SARS-CoV-2 and Pandemic Potential RNA Viruses: A Comparative Analysis |
Nikhil Chakravarty, Thrisha Senthilnathan, Sophia Paiola, Priya Gyani, Sebastian Castillo Cario, Estrella Urena, et al. (+9) Akash Jeysankar, Prakash Jeysankar, Joseph Ignatius Irudayam, Sumathi Natesan Subramanian, Helen Lavretsky, Shantanu Joshi, Gustavo Garcia, Arunachalam Ramaiah, Vaithilingaraja Arumugaswami |
10 |
[GO] |
2021―Aug―19 |
Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production |
Elisabeth Yaneske, Guido Zampieri, Loris Bertoldi, Giuseppe Benvenuto, Claudio Angione |
11 |
[GO] |
2021―Aug―19 |
Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination |
Aditya K. Padhi, Jagneshwar Dandapat, Prakash Saudagar, Vladimir N. Uversky, Timir Tripathi |
12 |
[GO] |
2021―Aug―10 |
A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E |
Tomoko Watanabe, Ko Takeda, Keiko Hiemori, Toshikazu Minamisawa, Hiroaki Tateno |
13 |
[GO] |
2021―Jul―31 |
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice |
Ralf Salzer, Jordan J. Clark, Marina Vaysburd, Veronica T. Chang, Anna Albecka, Leo Kiss, et al. (+9) Parul Sharma, Andres Gonzalez Llamazares, Anja Kipar, Julian A. Hiscox, Andrew Owen, A. Radu Aricescu, James P. Stewart, Leo C. James, Jan Löwe |
14 |
[GO] |
2021―Mai―15 |
A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization |
Benjamin C. Jennings, Stuart Kornfeld, Balraj Doray |
15 |
[GO] |
2021―Mai―09 |
Serum Levels of the IgA Isotype Switch Factor TGF-β1 are Elevated in Patients with COVID-19 |
Er-yi Wang, Hao Chen, Bao-qing Sun, Hui Wang, Hui-Qi Qu, Yichuan Liu, et al. (+8) Xi-zhuo Sun, Jingchun Qu, Zhang-fu Fang, Lifeng Tian, Yi-feng Zeng, Shau-Ku Huang, Hakon Hakonarson, Zhi-gang Liu |
16 |
[GO] |
2021―Mrz―17 |
Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2’s Spike Protein and Human ACE2 Receptor |
Binquan Luan, Haoran Wang, Tien Huynh |
17 |
[GO] |
2021―Jan―16 |
Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV2 spike protein |
Sayan Bhattacharjee, Rajanya Bhattacharyya, Jayati Sengupta |
18 |
[GO] |
2020―Sep―24 |
Basic and applied science at the time of Covid-19 |
Raffaele Porta, Claudia Martini |
19 |
[GO] |
2020―Aug―15 |
Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19 |
Karolina Pierzynowska, Lidia Gaffke, Grzegorz Węgrzyn |
20 |
[GO] |
2020―Jun―11 |
Transforming a research institute into a COVID diagnostic centre - scientists step forward to protect public health during the coronavirus pandemic |
Daniela Ruffell |
21 |
[GO] |
2020―Mai―25 |
SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection |
Kourosh Honarmand Ebrahimi |
22 |
[GO] |
2020―Mai―07 |
Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs |
Atsushi Hijikata, Clara Shionyu-Mitsuyama, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Tsuyoshi Shirai |
23 |
[GO] |
2020―Apr―04 |
Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic |
Daniela Ruffell |